Lv1
40 积分 2025-04-23 加入
ABS0364 SAFETY AND EFFICACY OF T CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE
7小时前
求助中
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
7小时前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
12天前
已完结
Mast Cell Biology at Molecular Level: a Comprehensive Review
13天前
已完结
FcεRI Expression and Dynamics on Mast Cells
13天前
已完结
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling
21天前
已完结
Development of a minimally immunogenic variant of humanized anti-carcinoma monoclonal antibody CC49
1个月前
已完结
Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue
1个月前
已关闭
Autoimmune gastritis
1个月前
已完结
The effect of c-Kit inhibition on mast cells in skin, colon, and lung (39.46)
1个月前
已关闭
皖公网安备34019202002308
